Insight
Yelena Y. Janjigian
Memorial Sloan Kettering Cancer Center/X

ICYMI from ASCO25: Yelena Y. Janjigian Shared Research from a Clinical Trial – MSKCC

Memorial Sloan Kettering Cancer Center shared a post on X:
“ICYMI from ASCO: Yelena Y. Janjigian shared research from a clinical trial that demonstrated a powerful new approach to help prevent cancer from coming back after treatment for stomach cancer and cancer of the lower portion of the esophagus and esophageal junction.
Learn more about the research.”

Yelena Y. Janjigian

Read OncoDaily’s Special Articles about ASCO 2025:

Highlights from ASCO 2025 Day 1

Highlights from ASCO 2025 Day 2

Highlights from ASCO 2025 Day 3

Highlights from ASCO 2025 Day 4

Yelena Y. Janjigian

ASCO ASCO 2025 ASCO25 cancer esophageal cancer Memorial Sloan Kettering Cancer Center OncoDaily Oncology stomach cancer Yelena Y. Janjigian